You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

CLINICAL TRIALS PROFILE FOR SILPHEN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SILPHEN

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01158820 ↗	Alternative Sedation During Bronchoscopy	Completed	Hospira, Inc.	Phase 4	2010-06-01	This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗	Alternative Sedation During Bronchoscopy	Completed	Hospira, now a wholly owned subsidiary of Pfizer	Phase 4	2010-06-01	This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗	Alternative Sedation During Bronchoscopy	Completed	University of Pennsylvania	Phase 4	2010-06-01	This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SILPHEN

Condition Name

Chart
Table

Condition Name for SILPHEN
Intervention	Trials
Sedation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SILPHEN
Intervention	Trials
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SILPHEN

Trials by Country

Map
Table

Trials by Country for SILPHEN
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SILPHEN
Location	Trials
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SILPHEN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SILPHEN
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SILPHEN
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SILPHEN

Sponsor Name

Chart
Table

Sponsor Name for SILPHEN
Sponsor	Trials
Hospira, Inc.	1
Hospira, now a wholly owned subsidiary of Pfizer	1
University of Pennsylvania	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SILPHEN
Sponsor	Trials
Industry	2
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.